What's in Marin L. Schweizer, PhD's pipeline?

Marin L. Schweizer, PhD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Marin L. Schweizer, PhD's portfolio?

Top competitors by shared drug class: Altacor Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/marin-l-schweizer-phd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Marin L. Schweizer, PhD — Portfolio Competitive Intelligence Brief

Marin L. Schweizer, PhD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Povidone-Iodine Topical Ointment	Povidone-Iodine Topical Ointment	marketed	Topical antiseptic/antimicrobial	Microbial proteins and nucleic acids (non-specific oxidative mechanism)	Dermatology / Infection Prevention

Therapeutic area mix

Dermatology / Infection Prevention · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Altacor Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Marin L. Schweizer, PhD:

Cite this brief

Drug Landscape (2026). Marin L. Schweizer, PhD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/marin-l-schweizer-phd. Accessed 2026-05-16.